Phase II Study Evaluating the Addition Of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients with Locally Advanced Squamous Cell Carcinomas of the Head and Neck

PURPOSE: To report the mature data of a prospective Phase II trial designed to evaluate the efficacy of an epidermal growth factor receptor inhibitor cetuximab (CTX) added to the concurrent therapy of weekly paclitaxel/carboplatin (PC) and daily radiation therapy (RT). METHODS AND MATERIALS: From 20...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Radiat Oncol Biol Phys
Main Authors: Suntharalingam, Mohan, Kwok, Young, Goloubeva, Olga, Parekh, Arti, Taylor, Rodney, Wolf, Jeffrey, Zimrin, Ann, Strome, Scott, Ord, Robert, Cullen, Kevin J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4447113/
https://ncbi.nlm.nih.gov/pubmed/21601372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2011.02.062
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados